# Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and Free Flap Survival in Patients Undergoing Oral Cancer Radical Surgery: A Randomized Controlled Clinical Trial.

> **NCT07401641** · NA · RECRUITING · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 60 (estimated)

## Conditions studied

- Oral Cancer
- Postoperative Pain Management
- Free Tissue Flaps
- Mouth Neoplasms

## Interventions

- **DRUG:** Dezocine and Sufentanil combination
- **DRUG:** Nalbuphine and Sufentanil combination

## Key facts

- **NCT ID:** NCT07401641
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07401641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07401641, "Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and Free Flap Survival in Patients Undergoing Oral Cancer Radical Surgery: A Randomized Controlled Clinical Trial.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07401641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*